retatrutide phase 2 trial obesity nejm 2023 Retatrutide: 3 Results (Up to 28.7% Weight Loss), Mechanism, Trials & 2026 Updates The next generation of weight-loss

A, Diagram of the proglucagon gene and encoded mRNA

At week 26, LDL-C was reduced by 19.0% (-36.0% to -1.9%, p=.029) in the tirzepatide 15 mg group compared to placebo while it was reduced by 17.8% (-33.7% to -2.0%, p= 0.028) in the dulaglutide 1.5 mg group compared to placebo though differences between the 2 medications were not seen [60]

Ready to make every mouthful count

Your appetite suppression may deepen and your energy expenditure (fat metabolism, fat loss) may improve but that also means youll want to ensure youre eating enough protein, maintaining lean mass, staying hydrated, and not inadvertently losing muscle mass

Disclaimer: This guide is for informational purposes regarding over-the-counter (OTC) management

The GLP-1 agonist discontinuation experience provides context for what retatrutide cessation might involve